EpiPen maker's CEO set to defend prices amid public outcry 1 234 567

EpiPen maker's CEO set to defend prices amid public outcry

cbc.ca

Mylan faces new scrutiny over price hikes for its anti-allergy EpiPen

Full news

Share:

More:

1 234 567

1 234 567

1 234 567

1 234 567

1 234 567

1 234 567